Amazon Unveils AI Drug Discovery, Alzheimer Drugs Offer Little Benefit, Shigella Resistance Surges No Oral Cure, Ancient DNA Rewrites Evolution, and more...

Amazon Unveils AI Drug Discovery, Alzheimer Drugs Offer Little Benefit, Shigella Resistance Surges No Oral Cure, Ancient DNA Rewrites Evolution, and more...

From Science News Daily by brief.news

April 16, 2026 · 12 min

About this episode

This episode discusses Amazon's new AI drug discovery platform, the limited benefits of Alzheimer's drugs, rising drug-resistant Shigella infections, and insights from ancient DNA studies on human evolution.

(0:10): Amazon Launches AI-Powered Bio Discovery Platform to Revolutionize Drug Research (2:02): Anti-Amyloid Alzheimer's Drugs Show Minimal Benefits, High Costs: Cochrane Review Raises Concerns (4:13): CDC Warns of Rising Drug-Resistant Shigella Infections, No Oral Treatment Available (6:27): Ancient DNA Study Unveils Extensive Human Evolution Since Farming Era (8:46): Groundbreaking Atlas Maps Human Liver Gene Expression, Reveals Unique Zonation Patterns and Disease Insights To subscribe visit https://www.brief.news . For more updates in your inbox each morning visit www.brief.news . Image credit: CNA

Topics covered

  • AI in drug discovery
  • Alzheimer's treatment
  • drug resistance
  • human evolution
  • gene expression

Keywords

  • AI drug discovery
  • Alzheimer's drugs
  • Shigella resistance
  • ancient DNA
  • gene expression

Mentioned in this episode

Organizations: Amazon, Cochrane, CDC, Atlas

More episodes of Science News Daily

Explore listener stats, chart rankings, contacts and more on the Science News Daily podcast page.